Domiciliary ventilation

To treat neuromuscular and chest wall conditions

Domiciliary (at home) ventilation is used to treat a range of common and complex neuromuscular, chest wall and respiratory conditions, including chronic obstructive pulmonary disease, sleep apnoea, muscular dystrophy and breathing problems related to motor neurone disease. This non-invasive, home ventilation treatment supports the lungs using a breathing device – usually a mask – attached to an electrically-operated ventilator. The Royal Brompton Hospital is the largest centre in Europe providing domiciliary ventilation.

What are the benefits?

For many patients, this ongoing treatment can reduce hospital admissions, extend survival and improve quality of life. Domiciliary ventilation is non-invasive and is designed to be used at home without medical assistance, meaning patients can spend less time in hospital.

Are there any alternatives?

Non-invasive home ventilation uses small, portable ventilators with a nasal or oral mask at night, supporting a person’s lungs as they sleep. This is a breakthrough in the treatment of sleep disorders linked to lung conditions and there are currently no more effective alternatives.

What are the risks?

Risks associated with domiciliary ventilation relate to power supply and hygiene, rather than the treatment itself. Because the ventilator is electronically-operated, it relies on an uninterrupted power supply; therefore it can stop working if there is a power cut, for example. There is a small risk of infection if the proper care and hygiene guidelines are not followed by the patient themselves, or their carer.

Consultants linked to treatment

Location where service is offered

Royal Brompton Hospital 

Book an appointment